- Home
- KTTA vs XWEL Comparison
KTTA vs XWEL Comparison
Compare KTTA & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- XWEL
- Stock Information
- Founded
- KTTA 2020
- XWEL 2006
- Country
- KTTA United States
- XWEL United States
- Employees
- KTTA N/A
- XWEL N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- KTTA Health Care
- XWEL Consumer Discretionary
- Exchange
- KTTA Nasdaq
- XWEL Nasdaq
- Market Cap
- KTTA 5.5M
- XWEL 6.2M
- IPO Year
- KTTA 2021
- XWEL N/A
- Fundamental
- Price
- KTTA $0.81
- XWEL $0.99
- Analyst Decision
- KTTA
- XWEL
- Analyst Count
- KTTA 0
- XWEL 0
- Target Price
- KTTA N/A
- XWEL N/A
- AVG Volume (30 Days)
- KTTA 93.8K
- XWEL 30.2K
- Earning Date
- KTTA 11-12-2025
- XWEL 11-13-2025
- Dividend Yield
- KTTA N/A
- XWEL N/A
- EPS Growth
- KTTA N/A
- XWEL N/A
- EPS
- KTTA N/A
- XWEL N/A
- Revenue
- KTTA N/A
- XWEL $30,601,000.00
- Revenue This Year
- KTTA N/A
- XWEL N/A
- Revenue Next Year
- KTTA N/A
- XWEL N/A
- P/E Ratio
- KTTA N/A
- XWEL N/A
- Revenue Growth
- KTTA N/A
- XWEL N/A
- 52 Week Low
- KTTA $0.65
- XWEL $0.70
- 52 Week High
- KTTA $5.45
- XWEL $2.00
- Technical
- Relative Strength Index (RSI)
- KTTA 61.44
- XWEL 40.51
- Support Level
- KTTA $0.70
- XWEL $0.97
- Resistance Level
- KTTA $0.84
- XWEL $1.02
- Average True Range (ATR)
- KTTA 0.03
- XWEL 0.07
- MACD
- KTTA 0.01
- XWEL -0.01
- Stochastic Oscillator
- KTTA 81.57
- XWEL 9.59
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.